Logo image of AWRE

AWARE INC/MASS (AWRE) Stock Fundamental Analysis

NASDAQ:AWRE - Nasdaq - US05453N1000 - Common Stock - Currency: USD

1.58  +0.02 (+1.28%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AWRE. AWRE was compared to 283 industry peers in the Software industry. AWRE has a great financial health rating, but its profitability evaluates not so good. AWRE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AWRE has reported negative net income.
In the past year AWRE has reported a negative cash flow from operations.
AWRE had negative earnings in each of the past 5 years.
In the past 5 years AWRE reported 4 times negative operating cash flow.
AWRE Yearly Net Income VS EBIT VS OCF VS FCFAWRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -17.10%, AWRE is doing worse than 68.36% of the companies in the same industry.
AWRE has a Return On Equity (-23.45%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -17.1%
ROE -23.45%
ROIC N/A
ROA(3y)-10.4%
ROA(5y)-12.09%
ROE(3y)-13.21%
ROE(5y)-14.38%
ROIC(3y)N/A
ROIC(5y)N/A
AWRE Yearly ROA, ROE, ROICAWRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15 -20

1.3 Margins

AWRE has a Gross Margin of 93.78%. This is amongst the best in the industry. AWRE outperforms 97.82% of its industry peers.
In the last couple of years the Gross Margin of AWRE has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AWRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.15%
AWRE Yearly Profit, Operating, Gross MarginsAWRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

8

2. Health

2.1 Basic Checks

AWRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AWRE has less shares outstanding
AWRE has less shares outstanding than it did 5 years ago.
AWRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AWRE Yearly Shares OutstandingAWRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
AWRE Yearly Total Debt VS Total AssetsAWRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

AWRE has an Altman-Z score of 0.14. This is a bad value and indicates that AWRE is not financially healthy and even has some risk of bankruptcy.
AWRE has a Altman-Z score of 0.14. This is in the lower half of the industry: AWRE underperforms 71.64% of its industry peers.
AWRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.14
ROIC/WACCN/A
WACC13.99%
AWRE Yearly LT Debt VS Equity VS FCFAWRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

AWRE has a Current Ratio of 4.32. This indicates that AWRE is financially healthy and has no problem in meeting its short term obligations.
AWRE has a better Current ratio (4.32) than 84.73% of its industry peers.
A Quick Ratio of 4.32 indicates that AWRE has no problem at all paying its short term obligations.
The Quick ratio of AWRE (4.32) is better than 84.73% of its industry peers.
Industry RankSector Rank
Current Ratio 4.32
Quick Ratio 4.32
AWRE Yearly Current Assets VS Current LiabilitesAWRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

AWRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.54%, which is quite good.
The Revenue has decreased by -5.38% in the past year.
AWRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.49% yearly.
EPS 1Y (TTM)11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)-5.38%
Revenue growth 3Y17.28%
Revenue growth 5Y2.49%
Sales Q2Q%-39.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y10.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AWRE Yearly Revenue VS EstimatesAWRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AWRE Yearly EPS VS EstimatesAWRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.1 -0.2 -0.3

0

4. Valuation

4.1 Price/Earnings Ratio

AWRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AWRE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AWRE Price Earnings VS Forward Price EarningsAWRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AWRE Per share dataAWRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AWRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AWARE INC/MASS

NASDAQ:AWRE (2/24/2025, 11:24:44 AM)

1.58

+0.02 (+1.28%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners20.66%
Inst Owner Change-97.59%
Ins Owners42.5%
Ins Owner Change0.24%
Market Cap33.50M
Analysts82.86
Price TargetN/A
Short Float %0.37%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.97
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.8
BVpS1.5
TBVpS1.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.1%
ROE -23.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.78%
FCFM N/A
ROA(3y)-10.4%
ROA(5y)-12.09%
ROE(3y)-13.21%
ROE(5y)-14.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.15%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.33%
Cap/Sales 0.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.32
Quick Ratio 4.32
Altman-Z 0.14
F-Score4
WACC13.99%
ROIC/WACCN/A
Cap/Depr(3y)34.39%
Cap/Depr(5y)42.78%
Cap/Sales(3y)1.61%
Cap/Sales(5y)1.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
EPS Next Y10.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.38%
Revenue growth 3Y17.28%
Revenue growth 5Y2.49%
Sales Q2Q%-39.66%
Revenue Next Year9.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.63%
FCF growth 3YN/A
FCF growth 5Y32.05%
OCF growth 1Y85.98%
OCF growth 3YN/A
OCF growth 5Y22.53%